Dr. Laure Ysebrant de Lendonck : Médecine interne et immunologie
Graduated in Internal medicine, my work experiences include positions in several Internal Medicine and hematology departments in Belgium and USA. I pursued research at the Center for Cell Engineering of the Memorial Sloan Kettering (MSKCC) in New York City in order to strengthen my expertise in immunology and cellular therapy. I had the opportunity to study the contribution of the microbiome on immune response and I developed metabolic strategies to promote immune cell survival. Fascinated by the importance of the microbiome in human health, its sensitivity to our occidental lifestyle and the implications of its unbalance in the development of our modern plagues, I wrote a book to inspire kids to take care of their microbiome. During this period, I developed a keen interest for preventive medicine which bridged the gap from conventional medicine to a more integrative practice. Back in Belgium, one of my major goals is to develop personalized strategies tailored for each patient based on precision testing, nutritional guidance and conventional therapies to promote long-term health and wellness.
Work Experiences and Education
- 2014-2017: Cell Therapy, Professor Michel Sadelain. Memorial Sloan Kettering Cancer Center, New York, USA.
- 2011-2013: Hematology, Professor Dominique Bron. Jules Bordet Institute, Bruxelles, Belgium.
- 2007-2011: Immunology, Professor Michel Goldman. Institute for medical immunology, Bruxelles, Belgium.
- 2004-2011: Residency in Internal Medicine, Professor Elie Cogan. Université Libre de Bruxelles, Belgium.
- 1997-2004: Medical School Université Libre de Bruxelles, Belgium.
Honours an Awards
- 2015 : Laureate of the Medic Prize. A career development award attributed each year to a particularly promising young clinician.
- 2015: Laureate of Nuovo Soldati Foundation.
- 2014: Laureate of Belgian American Education Foundation.
- 2014 : Subside from La Fondation Contre le Cancer.
- 2012: Prize from Immunity journal for the best poster at the World Immune Regulation Meeting Davos Switzerland.
Interferon Regulatory Factor 3 controls Interleukin-17 Expression in CD8 T lymphocytes.
- 2004: Prize from the Institute of Clinical Biology at the U.L.B. for the best thesis (memoires) .
Predictive markers for development of severe organ involvement in patients with systemic sclerosis. 2004.